Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs

Detalhes bibliográficos
Autor(a) principal: Francisco, R.
Data de Publicação: 2021
Outros Autores: Neves, M. C., Pereira, M. M., Sousa, A. C. A., Freire, M. G.
Idioma: eng
Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Texto Completo: http://hdl.handle.net/10773/34487
Resumo: Cytostatic drugs are one of the most used therapeutic options to treat cancer. Considering that cancer prevalence is increasing at a fast rate, the consumption of these drugs is expected to increase in the future. Upon administration, cytostatics are mainly excreted trough urine. This urinary excretion is responsible for the contamination of sewage, wastewater treatment plants (WWTPs) effluents, and ultimately of the aquatic environment. Consequently, cytostatic drugs were already detected in estuaries, rivers, lakes and even in drinking water. Given the high toxicity of these drugs and the inefficacy of the current technologies for their removal, disruptive technologies are necessary in order to mitigate this serious environmental and public health problem. In this line, we aim to remove these drugs before they reach the water cycle, i.e., directly from the contamination source (urine). In order to achieve this goal, Supported Ionic liquids (SILs) are here investigated since they combine the advantages of solid supports and the tunable characteristics of ILs. Several SILs using silica as the support material have been prepared and chemically and morphologically characterized. The SILs adsorption capacity for distinct cytostatic drugs, namely cyclophosphamide (CP), mycophenoloate mofetil (MMF) and mycophenolic acid (MPA) was evaluated by determining adsorption kinetics and isotherms. Overall, the ILs’ cation structure plays the most relevant role in the removal efficiency of cytostatics from aqueous samples and urine, with the developed materials showing a significantly higher performance than non-modified silica and activated carbon.
id RCAP_c3a929cea68471d7105bc7a3d1615da0
oai_identifier_str oai:ria.ua.pt:10773/34487
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugsCytostatic drugs are one of the most used therapeutic options to treat cancer. Considering that cancer prevalence is increasing at a fast rate, the consumption of these drugs is expected to increase in the future. Upon administration, cytostatics are mainly excreted trough urine. This urinary excretion is responsible for the contamination of sewage, wastewater treatment plants (WWTPs) effluents, and ultimately of the aquatic environment. Consequently, cytostatic drugs were already detected in estuaries, rivers, lakes and even in drinking water. Given the high toxicity of these drugs and the inefficacy of the current technologies for their removal, disruptive technologies are necessary in order to mitigate this serious environmental and public health problem. In this line, we aim to remove these drugs before they reach the water cycle, i.e., directly from the contamination source (urine). In order to achieve this goal, Supported Ionic liquids (SILs) are here investigated since they combine the advantages of solid supports and the tunable characteristics of ILs. Several SILs using silica as the support material have been prepared and chemically and morphologically characterized. The SILs adsorption capacity for distinct cytostatic drugs, namely cyclophosphamide (CP), mycophenoloate mofetil (MMF) and mycophenolic acid (MPA) was evaluated by determining adsorption kinetics and isotherms. Overall, the ILs’ cation structure plays the most relevant role in the removal efficiency of cytostatics from aqueous samples and urine, with the developed materials showing a significantly higher performance than non-modified silica and activated carbon.2022-08-30T16:28:20Z2021-01-01T00:00:00Z2021conference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10773/34487engFrancisco, R.Neves, M. C.Pereira, M. M.Sousa, A. C. A.Freire, M. G.info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-06T04:39:26Zoai:ria.ua.pt:10773/34487Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T14:15:43.962732Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
title Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
spellingShingle Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
Francisco, R.
title_short Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
title_full Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
title_fullStr Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
title_full_unstemmed Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
title_sort Supported ionic liquids as efficient strategies to reduce environmental contamination by cytostatic drugs
author Francisco, R.
author_facet Francisco, R.
Neves, M. C.
Pereira, M. M.
Sousa, A. C. A.
Freire, M. G.
author_role author
author2 Neves, M. C.
Pereira, M. M.
Sousa, A. C. A.
Freire, M. G.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Francisco, R.
Neves, M. C.
Pereira, M. M.
Sousa, A. C. A.
Freire, M. G.
description Cytostatic drugs are one of the most used therapeutic options to treat cancer. Considering that cancer prevalence is increasing at a fast rate, the consumption of these drugs is expected to increase in the future. Upon administration, cytostatics are mainly excreted trough urine. This urinary excretion is responsible for the contamination of sewage, wastewater treatment plants (WWTPs) effluents, and ultimately of the aquatic environment. Consequently, cytostatic drugs were already detected in estuaries, rivers, lakes and even in drinking water. Given the high toxicity of these drugs and the inefficacy of the current technologies for their removal, disruptive technologies are necessary in order to mitigate this serious environmental and public health problem. In this line, we aim to remove these drugs before they reach the water cycle, i.e., directly from the contamination source (urine). In order to achieve this goal, Supported Ionic liquids (SILs) are here investigated since they combine the advantages of solid supports and the tunable characteristics of ILs. Several SILs using silica as the support material have been prepared and chemically and morphologically characterized. The SILs adsorption capacity for distinct cytostatic drugs, namely cyclophosphamide (CP), mycophenoloate mofetil (MMF) and mycophenolic acid (MPA) was evaluated by determining adsorption kinetics and isotherms. Overall, the ILs’ cation structure plays the most relevant role in the removal efficiency of cytostatics from aqueous samples and urine, with the developed materials showing a significantly higher performance than non-modified silica and activated carbon.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01T00:00:00Z
2021
2022-08-30T16:28:20Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/34487
url http://hdl.handle.net/10773/34487
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833594447622832128